Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Breast Neoplasms

vidarabine has been researched along with Breast Neoplasms in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's10 (66.67)29.6817
2010's4 (26.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barkholt, L; Ericzon, BG; Mattsson, J; Omazic, B; Potácová, Z; Remberger, M; Ringdén, O; Söderdahl, G; Wersäll, P1
Kay, BK; Koduvayur, SP; Lavie, A; Su, Y1
Bos, GM; Fleskens, AJ; Jansen, RL; Lalisang, RI; Schouten, HC; van Gelder, M1
Bednarek, A; Fabianowska-Majewska, K; Rudnicka, K; Stefanska, B1
Albiin, N; Barkholt, L; Hentschke, P; Martola, J; Mattsson, J; Pisa, P; Remberger, M; Ringdén, O; Söderberg, M; Thörne, A; Uzunel, M; Wernerson, A; Wersäll, P1
Anderlini, P; Booser, DJ; Champlin, RE; Cheng, YC; Couriel, DR; de Lima, MJ; Gajewski, JL; Giralt, SA; Hortobagyi, GN; Hosing, C; Jonasch, E; Khouri, IF; Pagliaro, LC; Rondón, G; Tannir, NM; Ueno, NT1
Caracciolo, F; Fazzi, R; Galimberti, S; Petrini, M1
Bernardi, M; Bregni, M; Corradini, P; Deola, S; Fleischhauer, K; Guggiari, E; Lunghi, F; Mazzi, B; Monari, M; Peccatori, J; Pescarollo, A; Re, F; Scaramuzza, S; Servida, P; Setola, E1
Fabianowska-Majewska, K; Krawczyk, B1
Fabianowska-Majewska, K; Krawczyk, B; Rudnicka, K1
Bari, A; Brugiatelli, M; Buda, G; Gobbi, PG; Lazzaro, A; Lombardo, M; Luminari, S; Marcheselli, L; Marcheselli, R; Morabito, F; Pozzi, S; Quarta, G; Sacchi, S; Stelitano, C1
Friedberg, JW1
Hapke, DM; Mitchell, BS; Stegmann, AP1
Beltrami, G; Carella, AM; Cavaliere, M; Corsetti, MT; Lerma, E1
Da Prada, GA; Della Cuna, GR; Giorgiani, G; Giraldi, E; Landonio, G; Locatelli, F; Pedrazzoli, P; Schiavo, R; Siena, S; Zambelli, A1

Reviews

1 review(s) available for vidarabine and Breast Neoplasms

ArticleYear
Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
    Cancer treatment and research, 2002, Volume: 110

    Topics: Breast Neoplasms; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine

2002

Trials

2 trial(s) available for vidarabine and Breast Neoplasms

ArticleYear
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.
    Bone marrow transplantation, 2010, Volume: 45, Issue:3

    Topics: Adult; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Middle Aged; Myeloablative Agonists; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2010
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
    Blood, 2003, Nov-15, Volume: 102, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Renal Cell; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Male; Melphalan; Middle Aged; Neoplasm Metastasis; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2003

Other Studies

12 other study(ies) available for vidarabine and Breast Neoplasms

ArticleYear
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Myeloablative Agonists; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2016
Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Deoxycytidine Kinase; Drug Delivery Systems; Female; Humans; Ovarian Neoplasms; Phosphorylation; Receptor, ErbB-2; Tumor Cells, Cultured; Vidarabine

2016
Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
    European journal of pharmacology, 2010, Jul-25, Volume: 638, Issue:1-3

    Topics: Adenosine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cholecalciferol; Cladribine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Receptors, Retinoic Acid; Resveratrol; Stilbenes; Transcriptional Activation; Tretinoin; Vidarabine

2010
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
    Bone marrow transplantation, 2003, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Aged; Breast Neoplasms; Cholangiocarcinoma; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2003
Early reappearance of primary solid cancer in patients treated with purine analogs.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Colic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Purines; Remission Induction; Treatment Outcome; Vidarabine

2003
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
    Bone marrow transplantation, 2006, Volume: 37, Issue:3

    Topics: Adult; Biomarkers, Tumor; Bone Marrow; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Female; Gene Expression Regulation, Neoplastic; Graft Survival; Graft vs Tumor Effect; Humans; Mammaglobin A; Middle Aged; Myeloablative Agonists; Neoplasm Proteins; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Uteroglobin; Vidarabine

2006
Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues.
    Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11

    Topics: Azacitidine; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cladribine; Decitabine; DNA Methylation; Estrogen Receptor alpha; Genes, APC; Genes, BRCA1; Humans; K562 Cells; Nucleosides; Promoter Regions, Genetic; PTEN Phosphohydrolase; Vidarabine

2006
The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Nucleosides, nucleotides & nucleic acids, 2007, Volume: 26, Issue:8-9

    Topics: Antineoplastic Agents; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cladribine; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Genes, APC; Genes, BRCA1; Genes, Tumor Suppressor; Humans; Nucleosides; Promoter Regions, Genetic; PTEN Phosphohydrolase; Receptors, Retinoic Acid; Vidarabine

2007
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Haematologica, 2008, Volume: 93, Issue:3

    Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Italy; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radioimmunotherapy; Radiotherapy; Transplantation, Autologous; Vidarabine

2008
Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Haematologica, 2008, Volume: 93, Issue:3

    Topics: Acute Disease; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Italy; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Myelodysplastic Syndromes; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radioimmunotherapy; Radiotherapy; Transplantation, Autologous; Vidarabine

2008
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Cancer research, 1996, May-15, Volume: 56, Issue:10

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biotransformation; Breast Neoplasms; Carcinoma, Small Cell; Cladribine; Colonic Neoplasms; Cytarabine; Deoxycytidine Kinase; DNA, Complementary; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genetic Vectors; Humans; Lung Neoplasms; Moloney murine leukemia virus; Phosphorylation; Recombinant Fusion Proteins; Tumor Cells, Cultured; Vidarabine

1996
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Cancer, 2002, May-01, Volume: 94, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Renal Cell; Child; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Pilot Projects; Sarcoma; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2002